z-logo
open-access-imgOpen Access
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial
Author(s) -
David R. Boulware,
Thomas A. Murray,
Jennifer Proper,
Christopher J. Tignanelli,
John B. Buse,
David Liebovitz,
Jacinda M. Nicklas,
Kenneth J. Cohen,
Michael A. Puskarich,
Hrishikesh Belani,
Lianne Siegel,
Nichole R. Klatt,
David J. Odde,
Amy B. Karger,
Nicholas E. Ingraham,
Katrina M Hartman,
Via Rao,
Aubrey A Hagen,
Barkha Patel,
Sarah L. Fenno,
Nandini Avula,
Neha V Reddy,
Spencer M Erickson,
Sarah Lindberg,
Regina Fricton,
Samuel Lee,
Adnin Zaman,
Hanna G Saveraid,
Walker Tordsen,
Matthew F Pullen,
Nancy E. Sherwood,
Jared D. Huling,
Carolyn T. Bramante
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac772
Subject(s) - medicine , myalgia , vaccination , chills , clinical trial , nausea , severity of illness , randomized controlled trial , coronavirus , pediatrics , covid-19 , disease , immunology , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom